跳至主要内容
临床试验/NCT05973500
NCT05973500招募中不适用

Implementing Metabolomics Informed Diet on Inflammatory Bowel Disease Patients

University of California, San Diego2 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2023年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
90
试验地点
2
主要终点
short Crohn's Disease Activity Index (sCDAI)

研究概览

简要总结

The effects of diet on inflammatory bowel disease is an under-studied area of research. The investigators are interested in further investigating the role that diet contributes to inflammatory bowel disease severity. The investigators will collect blood and stool samples from patients with inflammatory bowel disease (IBD) before and after diet changes. The stool samples will be analyzed using metabolomics and microbiome analysis to determine changes after the new diet has been implemented. The investigators will then compare changes in the patient's overall disease state by measuring markers of inflammation including C-reactive protein (CRP) and fecal calprotectin to determine how this diet affects the disease state.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years old or older
  • Meet classification criteria for inflammatory bowel disease including those with mild to moderate Crohn's Disease as defined by a Crohn's disease activity index between 150-450, with fecal calprotectin>250, within 1 month of enrollment.

排除标准

  • Unable to provide informed consent
  • History of or current drug abuse
  • Pregnancy
  • Start or change in dose of standard-of-care treatment within 12 weeks of the screening
  • Known allergy to any component of the proposed diet
  • Subjects with significant other medical or psychiatric comorbidities and /or medication use which in
  • physician's clinical judgment might difficult the interpretation of the results
  • Patients that are not on a stable dose of medications, for instance, steroids, in between samples collection
  • Patients on antibiotics
  • Patients with C difficile infection within 4 weeks of enrollment

结局指标

主要结局

short Crohn's Disease Activity Index (sCDAI)

时间窗: 42 Days

Mild to moderate Crohn's Disease is defined by a short Crohn's Disease activity index (sCDAI) between 150-450, while those in remission from Crohn's Disease have an sCDAI score below 150. An sCDAI score exceeding 450 is used as a marker of severe Crohn's Disease.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Monica Guma

Associate Professor

University of California, San Diego

研究点 (2)

Loading locations...

相似试验

Effect of Mediterranean Diet in Inflammatory Bowel... | 临床试验